➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Dow
Baxter
Express Scripts
Mallinckrodt
Harvard Business School

Last Updated: July 10, 2020

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 090356


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

NDA 090356 describes NALTREXONE HYDROCHLORIDE, which is a drug marketed by Accord Hlthcare, Apotex, Barr, Elite Labs, Fosun Pharma, Specgx Llc, and Sun Pharm, and is included in seven NDAs. It is available from eleven suppliers. Additional details are available on the NALTREXONE HYDROCHLORIDE profile page.

The generic ingredient in NALTREXONE HYDROCHLORIDE is naltrexone hydrochloride. There are nineteen drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the naltrexone hydrochloride profile page.
Summary for 090356
Tradename:NALTREXONE HYDROCHLORIDE
Applicant:Sun Pharm
Ingredient:naltrexone hydrochloride
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 090356
Mechanism of ActionOpioid Antagonists
Suppliers and Packaging for NDA: 090356
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
NALTREXONE HYDROCHLORIDE naltrexone hydrochloride TABLET;ORAL 090356 ANDA Major Pharmaceuticals 0904-7036 0904-7036-04 30 BLISTER PACK in 1 CARTON (0904-7036-04) > 1 TABLET, FILM COATED in 1 BLISTER PACK
NALTREXONE HYDROCHLORIDE naltrexone hydrochloride TABLET;ORAL 090356 ANDA Sun Pharmaceutical Industries, Inc. 47335-326 47335-326-08 100 TABLET, FILM COATED in 1 BOTTLE (47335-326-08)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength50MG
Approval Date:Feb 24, 2012TE:ABRLD:No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
AstraZeneca
McKesson
Mallinckrodt
Express Scripts
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.